Cargando…
An open clinical evaluation of selected siddha regimen in expediting the management of COVID-19 –a randomized controlled study
BACKGROUND: The corona virus disease 2019 (COVID-19), an acute respiratory disease, caused by a novel corona virus (SARS-CoV-2, previously known as 2019-nCoV), obtained worldwide attention. In this review, we explored the potential siddha strategies for COVID -19 infections. OBJECTIVES: To evaluate...
Autores principales: | Chitra, S.M., Mallika, P., Anbu, N., Narayanababu, R., Sugunabai, A., David Paul Raj, R.S., Premnath, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826002/ https://www.ncbi.nlm.nih.gov/pubmed/33519133 http://dx.doi.org/10.1016/j.jaim.2021.01.002 |
Ejemplares similares
-
A clinical study of Panchakola Siddha Yavagu in the management of Agnimandya
por: More, Sangita D., et al.
Publicado: (2011) -
Siddha management of alcohol withdrawal syndrome
por: Selvasankari, E, et al.
Publicado: (2022) -
Toxicity Evaluation of Pũrṇa Cantirotaya Centũram, a Siddha Medicine in Wistar Rats
por: Chitra, B., et al.
Publicado: (2015) -
STANDARDISATION OF SIDDHA DRUGS
por: Saraswathy, Ariamuthu
Publicado: (1994) -
Safety and efficacy of a Siddha Medicine fixed regimen for the treatment of asymptomatic and mild COVID-19 patients
por: Kannan, M., et al.
Publicado: (2022)